Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of Tuesday, September 1, 2026.
PE RATIO
N/A
Market Cap
$5.41B
PE Ratio
37.46
TTM Avg
37.36
3Y Avg
43.37
5Y Avg
55.01
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scholar Rock Holding Corporation (SRRK) | $6.81B | N/A | N/A | N/A | N/A |
| Chemed Corporation (CHE)vs › | $6.78B | 26.04 | 23.63 | 28.16 | 28.43 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.60B | N/A | 61.96 | 88.48 | 88.48 |
| Oscar Health, Inc. (OSCR)vs › | $7.77B | 21.40 | 21.68 | 52.20 | 52.20 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.41B | 37.46 | 37.36 | 43.37 | 55.01 |
| Doximity, Inc. (DOCS)vs › | $5.00B | 31.42 | 32.35 | 43.78 | 74.34 |
| The Ensign Group, Inc. (ENSG)vs › | $10.04B | 27.00 | 31.08 | 30.43 | 27.62 |
| Henry Schein, Inc. (HSIC)vs › | $10.23B | 26.18 | 23.58 | 23.80 | 21.76 |
| Insulet Corp. (PODD)vs › | $10.30B | 27.79 | 65.86 | 70.28 | 3680.68 |
| Universal Health Services, Inc. (UHS)vs › | $10.31B | 6.99 | 8.83 | 12.16 | 12.18 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$56.80
Forward EPS (Est.)
$-3.33
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
